Mob ntshav qab zib hom 2 tuaj yeem ua tau Tom ntej: Bioglutide NA-931 peptidezoo li ob zaug nyuaj. Ua kom koj cov ntshav qab zib nyob hauv kev kuaj xyuas yog qhov nyuaj, thiab kev hnyav hnyav ua rau cov tshuaj insulin tsis kam. Tsis yog tag nrho cov teeb meem metabolic raug kho raws li cov tib neeg tau zoo, ua rau nws nyuaj kom ua tau zoo tag nrho. Bioglutide NA-931 peptide, ib qho tshuaj me me uas nqos tau, hloov kev kho mob metabolic. Cov tshuaj no tsom rau GIPR, IGF-1R, GLP-1R, thiab GCGR ib txhij, tsis zoo li lwm tus. Cov txheej txheem multi-receptor tswj cov piam thaj tsis txaus thiab qhov hnyav siv cov txheej txheem lom neeg. Cov lus teb no yog cov ncauj lus kom ntxaws ntxiv rau cov neeg mob ntshav qab zib hom 2.
1. General Specification (hauv Tshuag)
(1) API (Ntshiab hmoov)
PE / Al foil hnab / ntawv lub thawv rau cov hmoov ntshiab
(2) Spot-On
(3) Kev daws teeb meem
(4) Poob
2.Customization:
Peb yuav sib tham tus kheej, OEM / ODM, Tsis muaj hom, rau kev tshawb nrhiav kev ruaj ntseg nkaus xwb.
Khoom siv: BM-1-154
TIAB SA-931
Kev tshuaj xyuas: HPLC, LC-MS, HNMR
Kev them nyiaj yug Technology: R & D Dept.-3

Peb muab NA-931 peptide, thov xa mus rau lub vev xaib hauv qab no kom paub meej cov lus qhia thiab cov khoom lag luam.
Khoom siv:https://www.bloomtechz.com/synthetic-chemical/peptide/na-931-peptide.html
Dab tsi ua rau qhov txhaj tshuaj peptide tshwj xeeb? Direct bioavailability tshem tawm cov mob txhua hnub. Nrog tshaj 98% purity, cov hmoov dawb yog ruaj khov ntawm qhov kub thiab txias. Kev ua kom txaus txaus rau kev siv kho mob pab tshawb fawb cov koom haum thiab cov tuam txhab tshuaj tsim cov tshuaj metabolic tshiab. Raws li Bioglutide NA-931 peptide qhia, metabolic hormone networks tau tshawb fawb ntau. Txhua lub hom phiaj receptor cuam tshuam rau lub cev sib txawv, tab sis ua ke lawv ua ntau dua. Cov kev tshawb fawb soj ntsuam tau pom tias txo qis hauv cov ntshav qab zib, HbA1c, thiab lub cev hnyav thaum tswj cov leeg nqaij ntshiv. Qhov no txawv nws los ntawm lwm yam tshuaj poob phaus.
Yuav ua li cas Bioglutide NA-931 Peptide txhawb nqa ob leeg ntshav qab zib thiab tswj qhov hnyav?
Dual{0}}Action Mechanism Los Ntawm Receptor Synergy
Lub luag haujlwm tseem ceeb ntawm bioglutide NA-931 peptide yog los tswj cov haujlwm metabolic. Ntau cov tshuaj kho mob ntshav qab zib laus tau txhim kho insulin ua haujlwm lossis nce insulin ntau lawm. Txawm li cas los xij, qhov hnyav-cov tshuaj poob feem ntau txo qis kev tshaib kev nqhis. Cov tshuaj no activates receptors rau ob qho tib si kev kho mob. Thaum GLP-1R tau qhib, lub hlwb ua kom lub hlwb nce ntxiv. Qhov no ib txwm txiav kev noj mov. Hloov koj cov cim kev tshaib kev nqhis kom noj tsawg dua. Raws li GIPR qhib, lub plab - txoj hauv kev ua rau pancreatic zog. Qhov no txhawb kev noj zaub mov -induced insulin. Kev npaj teb zoo yuav txo cov piam thaj tom qab noj mov. Cov spikes no ua rau cov hlab ntsha puas tsuaj thiab txhawb cov ntshav qab zib. Cov txiaj ntsig metabolic mus dhau kev tswj cov piam thaj.
Thaum tshwm sim, GCGR zom cov nqaij adipose rog thiab txhim kho cov metabolism. Tsiaj kev tshawb fawb qhia 15-20% nce zog. Tib neeg hlawv 200-300 calorie ntau ntau txhua hnub. Qhov tsis muaj zog ua rau lub lis piam thiab lub hlis poob phaus yam tsis hloov cov metabolism lossis calories.
Kev noj qab haus huv tswj thiab metabolic Efficiency
Hom 2 mob ntshav qab zib mellitus ua rau nws nyuaj rau rhuav tshem cov insulin- voj voog tshaib plab. Ntau cov tshuaj insulin yuav tsum tau tshem tawm cov piam thaj, tab sis nws kuj khaws cov rog thiab ua rau kev tshaib kev nqhis - tswj lub hlwb ua haujlwm hnyav dua. Kev poob phaus yog qhov nyuaj dua vim cov ntshav qab zib yog ib qho nyuaj rau tswj. Lub bioglutide NA-931 peptide lub plab khoob thiab satiety hormone tso tawm kho qhov no.
Kev ncua lub plab khoob ua rau ncua sij hawm tom qab- noj mov puv, txo cov khoom noj txom ncauj. Cov neeg koom nrog txoj kev tshawb fawb qhia tias noj 25-35% tsawg dua thiab tsis tshaib plab, nyuaj rau ntau cov zaub mov. To taub yuav ua li cas cov tshuaj tua cov rog yog qhov tseem ceeb. GCGR hloov cov triglycerides rau hauv cov roj fatty acids dawb thaum qhib. Tom qab nkag mus rau hauv cov hlab ntsha, cov kua qaub no tuaj yeem ua rau lub cev muaj zog. Yog li, lub siab ceev gluconeogenesis thiab ketone lub cev synthesis. Cov no muab lub zog lwm yam tshaj li kev noj zaub mov carbs. Qhov kev hloov pauv hormonal no pab koj txo qhov hnyav los ntawm kev khaws cia lub zog thaum koj lub cev txhim kho.
Khaws cov leeg thaum poob phaus
Cov neeg uas poob phaus sai sai txhawj txog cov leeg nqaij.
Peb tshem tawm cov piam thaj ntau hauv cov leeg, yog li nws yuav tsum muaj zog . 20-30% ntawm qhov hnyav koj poob los ntawm kev txo calories yog cov leeg. Nws cuam tshuam cov metabolism hauv lub sijhawm. IGF-1R ua kom los ntawm Bioglutide NA-931 peptide kho qhov no. Cov nqaij leeg satellite cell proliferate thiab tsim los ntawm cov kab mob zoo li insulin zoo li kev loj hlob. Tam sim no, protein degradation tso tseg. Cov neeg koom nrog poob txog 12% ntawm lawv qhov hnyav pib yam tsis tau poob cov leeg hauv Phase II. Cov tshuaj tiv thaiv cov nqaij ntshiv, tsis zoo li lwm cov tshuaj poob phaus. Qhov hnyav txo thiab cov leeg nqaij muaj zog muaj ntau yam txiaj ntsig kev noj qab haus huv. Koj cov metabolism tsis tuaj yeem kho kom tau qhov hnyav thaum so. Lub zog thiab kev ua haujlwm nyob twj ywm, yog li koj tuaj yeem tawm dag zog li qub los txhawb cov metabolism. Tag nrho cov leeg prolongs insulin rhiab heev. Qhov no tseem ceeb tshaj plaws. Koj tuaj yeem tswj cov ntshav qab zib tom qab kho.
Glucose Regulation Benefits of Bioglutide NA-931 Peptide
Txhim kho Insulin secretion thiab rhiab heev
Thaum pancreatic beta hlwb tsis tsim cov tshuaj insulin txaus, cov ntaub so ntswg tsis ua haujlwm. Ntshav qab zib Hom 2 tshwm sim los ntawm cov teeb meem no. Tswj ob qho kev txhawj xeeb ib zaug yog txoj hauv kev zoo tshaj plaws los kho cov ntshav sib npaug.Tom ntej: Bioglutide NA-931 peptideactivates GIPR, uas ua rau nce insulin ntau lawm hauv pancreatic beta hlwb thaum cov piam thaj nce ntxiv. Qhov no ua haujlwm zoo vim tias insulin tsuas yog ua sai dua ntawm cov ntshav qab zib. Cov tshuaj insulin uas ua haujlwm tsis hais cov piam thaj hauv ntshav muaj kev pheej hmoo ntawm hypoglycemia ntau dua li cov piam thaj -raws li insulin. Adipose, nqaij, thiab daim siab insulin ua haujlwm zoo nrog GLP-1R signaling. Ntau qhov rhiab heev ntawm insulin tshem tawm tib lub suab thaj nrog cov tshuaj insulin tsawg dua. Pancreatic beta hlwb muaj txiaj ntsig.
Cov ntaub so ntswg teb rau cov lus pom zoo ua rau cov qauv insulin ntau dua. Qhov no tuaj yeem txo qis beta cell poob hauv ntshav qab zib. Kev tshawb fawb theem II txo qis HbA1c 0.8% thiab ceev cov ntshav qabzib 1.2 mmol / L. Cov kev hloov no txhawb kev noj qab haus huv thiab txo qis CVD kev pheej hmoo. Xyoo -ntev qabzib nce qis dua retinopathy, nephropathy, thiab kev pheej hmoo neuropathy.
Kev txo qis hauv Glucagon thiab Hepatic Glucose Output
Kev tswj cov piam thaj nyob ntawm daim siab. Nws tso glycogen thiab ua kom qabzib los ntawm tsis yog -carbs. Kev yoo mov hyperglycemia feem ntau tshwm sim hauv cov neeg mob ntshav qab zib hom 2 vim tias lawv lub siab tsim cov piam thaj ntau dhau, tshwj xeeb tshaj yog thaum hmo ntuj.
Pancreatic alpha hlwb secrete glucagon, uas ua rau lub siab tso tawm suab thaj. Bioglutide NA-931 peptide suppresses glucagon tso tawm ntawm GIPR. Hepatic glucose synthesis txo qis. Qhov no yuav pab tau thaum yoo mov vim tias zaub mov tsawg txhais tau tias tsawg dua cov piam thaj. Nws ua rau lub siab tsis dhau glucagon blockade. GCGR txhawb kom lub siab siv fatty acids es tsis txhob triglycerides rau lub zog, ua kom cov metabolism hauv dej ntau dua. HEpatic steatosis nce ntshav qab zib hom 2 insulin tsis kam. Kho nws. Thaum lub siab noj qab nyob zoo, insulin tuaj yeem tiv thaiv kev tsim cov piam thaj.
Stabilization ntawm Postprandial Glucose Excursions
Tom qab- noj mov hauv ntshav qab zib yog qhov nyuaj los tswj cov ntshav qab zib.
Cov neeg noj zaub mov uas muaj cov zaub mov zoo li qub- nce ntshav qab zib feem ntau muaj cov piam thaj ntau txaus ntshai tom qab noj mov. Kev noj zaub mov zoo cuam tshuam rau cov kab mob plawv thiab kev pheej hmoo siab HbA1c. Bioglutide NA-931 peptide ua rau lub plab zom mov qeeb, txo qis carbs. Hauv lwm lo lus, qabzib circulates maj mam. Qhov kev faib tawm no txuas ntxiv txuam nrog pancreatic insulin secretion. Insulin nres cov piam thaj los ntawm kev nce nrawm dua li cov beta hlwb tuaj yeem ua haujlwm. GLP-1R thiab GIPR ua kom zoo dua tom qab- noj zaub mov tswj cov piam thaj los ntawm cov nyhuv incretin. Cov tshuaj hormones pancreatic, lub plab enzymes, thiab plab hnyuv motility yog tswj los ntawm incretins. Nws muaj peev xwm zom zaub mov. Raws li nyob rau hauv cov neeg uas tsis yog - mob ntshav qab zib, receptor activation thiab tswj cov lus teb txhawb cov ntshav qab zib tom qab noj mov. Qhov no pab cov teeb meem luv luv thiab ntev.
Bioglutide NA-931 Peptide puas tuaj yeem txhim kho cov txiaj ntsig metabolic hauv ntshav qab zib hom 2?
Cov ntaub ntawv pov thawj kho mob rau Metabolic Syndrome Cheebtsam
Feem ntau hom 2 mob ntshav qab zib tsis yog qhov tshwm sim. Cov kab mob metabolic muaj xws li kev rog rog, ntshav siab triglycerides, tsis zoo HDL cholesterol, ntshav siab, thiab insulin tsis kam. Qhov no yog qhov uas cov neeg txom nyem feem ntau muaj. Tag nrho cov xwm txheej no yuav tsum tau hais ib txhij los txhawb lub plab noj qab haus huv. Cov cim qhia metabolic syndrome ntawm Bioglutide NA-931 peptide cov neeg txais tau hloov pauv. Cov neeg koom nrog kev tshawb fawb txo qhov hnyav, qabzib, thiab txhim kho lipid profile. HDL cholesterol nce thaum triglycerides txo. Cov kev hloov pauv suav nrog ntau lub plab rog thiab txhim kho kev siv lub siab lipid. Ob qho tib si tseem ceeb heev rau kev tiv thaiv kab mob plawv.
Cov ntshav siab txo qis tsis tu ncua. Lawv yuav poob phaus, muaj ntau dua insulin-sensitive, thiab GLP-1R cov cim qhia tau cuam tshuam rau lawv cov hlab ntsha. Ntshav qab zib ua rau muaj kev pheej hmoo ntawm lub plawv nres thiab mob stroke, yog li cov neeg mob ntshav siab yuav tsum tau ntsuas ntxiv. Cov neeg mob tau txais txiaj ntsig ntau dua los ntawm kev kho ntau yam kab mob plawv nrog rau ib qho tshuaj. Txo qhov mob yog lwm qhov txiaj ntsig. Cov kab mob qis qis ua rau cov quav hniav thiab cov tshuaj insulin tsis kam. Kev poob phaus, tshwj xeeb tshaj yog nyob ib ncig ntawm lub duav, txo cov inflammatory cytokines. Koj lub cev kho sai dua. Kev tshem tawm o tuaj yeem piav qhia vim li cas cov kev hloov pauv hauv metabolic nyob ntev dua li kev poob phaus.
Ntev -Lub Sij Hawm Glycemic Control thiab Beta Cell Preservation
Cov tshuaj noj ntshav qab zib lub neej yog qhov tseem ceeb. Ntau cov tshuaj ua haujlwm zoo thaum pib tab sis ua rau muaj mob. Bioglutide NA-931 peptide yuav tsum nres lossis ncua kev mob, tsis yog zais cov tsos mob xwb. Raws li peb txoj kev tshawb fawb, cov teebmeem tuaj yeem cuam tshuam txog kev kis tus kabmob. Glucotoxicity tshwm sim los ntawm cov ntshav qab zib ntev ntev. Beta cells tuaj yeem tso cov tshuaj insulin tom qab cov piam thaj txo qis. Nrog rau kev ua kom zoo dua qub, insulin xav tau tsawg dua. Txo cov kev ua ntawm beta cell yuav ua rau lawv lub neej ntev.
Cov txiaj ntsig ntawm metabolic nco ua rau cov ntshav qabzib nruj tswj tau txiaj ntsig txawm tias nws hnyav dua. Kev noj qab haus huv ntawm cov piam thaj hauv cov ntshav thaum ntxov hauv kev mob hloov pauv ntawm tes siv lub zog, tsis txhob muaj teeb meem ntau xyoo. Kev kho thaum ntxov nrog Bioglutide NA-931 peptide tuaj yeem hloov pauv tus kab mob. Kev txhawb nqa lub tswv yim no yuav tsum tau kawm ntev -lub sij hawm kawm. Tus naj npawb ntawm cov teeb meem ntshav qab zib tau zam yog qhov pom zoo tshaj plaws ntawm kev kho mob. Cov ntshav qab zib ntev ntev tuaj yeem ua rau cov hlab ntsha hauv lub qhov muag, lub raum, thiab cov hlab ntsha puas, ua rau cov kab mob microvascular. Kev loj hlob sai ntawm atherosclerosis ua rau lub plawv nres thiab mob stroke. Ntau -receptor agonists tuaj yeem daws cov teeb meem ntau dua li cov phiaj xwm ib leeg los ntawm kev hloov ntau yam metabolic.
Tus neeg mob zoo ntawm lub neej thiab kev kho mob ua raws
Txawm tias cov tshuaj zoo yuav tsis pab yog tias noj tsawg. Qee qhov tsis lees txais cov tshuaj txhaj tshuaj vim lawv ntshai koob, muaj kev phiv, lossis siv nyuaj. Qhov ncaujTom ntej: Bioglutide NA-931 Peptidetshem tawm cov teeb meem no. Qhov no yuav ua rau nws zoo dua li tiag tiag - lub neej muaj zog txhaj tshuaj. Yuav ua li cas lub compound qhov kev tshaib kev nqhis thiab tag nrho cov txiaj ntsig tau muab ua rau txhua tus neeg zoo. Kev tshaib plab txhua lub sijhawm yuav ua rau kev noj zaub mov nyuaj, ua rau koj xav tias tsis ua haujlwm thiab xav nres. Txiav calories, poob tshaib plab. Qhov no ua rau kev hloov pauv kev noj zaub mov zoo li tsis tshaib plab thiab feem ntau- tswj tau.
Calorie- cov neeg saib xyuas xav tias muaj zog thaum lawv cov metabolism normalizes. Vim tias lub cev ua haujlwm zoo dua thiab khaws cov rog rau lub zog. Kev tawm dag zog yooj yim dua nrog lub zog ntau dua, uas muaj txiaj ntsig kev noj qab haus huv tshaj li tshuaj. Yog tias koj poob phaus thiab tswj cov ntshav qab zib thiab zoo dua, koj yuav lo nrog nws. Kev poob phaus ntau boosts koj txoj kev zoo nkauj thiab kev puas hlwb. Tus kheej -kev hwm thiab kev ruaj ntseg hauv zej zog cuam tshuam lub neej zoo. Txawm hais tias nyuaj los ntsuas, qhov zoo ntawm kev xav yog qhov tseem ceeb rau kev hloov tus cwj pwm thiab kev noj qab haus huv.
Kev sib raug zoo ntawm kev poob phaus thiab tswj glycemic
Mechanistic Links ntawm Adiposity thiab Insulin Resistance
Txhawm rau kom nkag siab tias vim li cas qhov hnyav txo qis txhawb cov metabolism, peb ua ntej tshuaj xyuas vim li cas cov rog ntau dhau ua rau insulin tsis kam. Cov kab mob endocrine ua haujlwm, cov ntaub so ntswg adipose tso tawm ntau yam tshuaj uas ua rau mob thiab cuam tshuam rau lub cev ua haujlwm. Adipocytes tsim cov tshuaj sib txawv thaum muaj roj ntau. Qhov no ua rau cov tshuaj insulin tsis kam. Visceral fat-organ-cov rog nyob ib puag ncig- phem dua. Nws ntws ncaj qha mus rau hauv lub portal ncig vim nws tsim. Qhov no muab ob peb adipokines thiab dawb fatty acids rau lub siab. Lub siab rog thiab insulin tsis kam ua rau lub siab puas tsuaj, ua rau mob ntshav qab zib tsis zoo.
Vim yog GCGR-mediated lipolysis, Bioglutide NA-931 peptide accelerates plab tshem tawm rog. Visceral adipocytes teb ntau zog rau cov lus qhia roj hlawv ntau dua li cov rog subcutaneous. Qhov no cia koj txo cov rog qhov twg koj cov metabolism raug kev txom nyem tshaj plaws. Thaum cov rog hauv plab txo qis, cov kab mob adipokine txo qis, ua rau kev siv tshuaj insulin zoo dua. Lub siab rog tsub zuj zuj kuj normalizes. Cov ntaub so ntswg adipose hloov dhau qhov shrinkage. Normalizing fat cell sizes tsub kom adiponectin ntau lawm thiab kho kom raug adiponectin tso tawm. Adiponectin txhim kho insulin thiab txo qhov mob. Qhov no yuav pab kom lub cev zoo. Txawm hais tias qhov hnyav tau rov qab los, qhov nce ntawm cov rog no pab txhawb cov metabolism.
Quantifying Glucose Benefits ntawm Kev Txom Nyem
Kev poob ib qho hnyav pab hom 2 mob ntshav qab zib tswj lawv cov ntshav qab zib, raws li tau ua pov thawj ntau zaus. Kev poob phaus 5% txo qis HbA1c los ntawm 0.5 txog 1.0%. Qhov hnyav poob ntawm 10-15% tuaj yeem ua rau 2.0% hloov pauv. Cov txiaj ntsig tshwm sim vim muaj ntau yam tshwm sim ib zaug. Inflammatory molecules poob tam sim ntawd thaum fatty cov ntaub so ntswg loj txo. Qhov no pab insulin sib txuas lus ntawm cov leeg thiab lub siab. Cells nyob rau hauv daim siab, thyroid, thiab cov nqaij ntshiv rov qab mus rau qhov qub thaum cov roj ntau dhau raug tshem tawm. Tsawg lub cev rog txo cov leeg nqaij thiab txhim kho kev ua kis las. Cov kev hloov pauv no, ua ke nrog kev tawm dag zog, txhim kho insulin ua haujlwm.
Qhov nruab nrab qhov hnyav txo ntawm 13.8% hauv Bioglutide NA-931 peptide kev tshawb fawb ntau dhau los txhim kho cov metabolism hauv lub neej tiag tiag. Cov neeg mob ntshav qab zib uas poob qhov hnyav no feem ntau mus rau hauv kev tshem tawm ntxov. Qhov no qhia tau tias lawv HbA1c qis dua li ib txwm muaj rau cov neeg mob ntshav qab zib tsis muaj tshuaj. Poob qhov hnyav ntau no txhim kho cov ntshav qab zib cov cai thiab txo qhov txaus ntshai. Qhov no muaj tseeb txawm rau cov neeg mob ntshav qab zib siab uas muaj ntau yam beta cell poob. Nco ntsoov tias txo qhov hnyav zoo li txhawb cov piam thaj txawm tias tsis txiav calories. Caloric txwv thiab kev phais bariatric ob leeg txo qhov hnyav, tab sis kev phais txhim kho cov metabolism.
Kev hloov pauv hauv plab hnyuv tso tawm thiab nqus tau zoo li muaj ntau yam teebmeem. Bioglutide NA-931 peptide tuaj yeem ua raws li qhov zoo ntawm cov tshuaj hormones yam tsis muaj kev phais los ntawm kev ua kom muaj ntau yam receptors.
Ua txhaum lub voj voog ntawm qhov hnyav nce thiab txo qis kev tswj cov piam thaj
Hom 2 mob ntshav qab zib mob hnyav zuj zus. Kev kho mob yuav tsum nce ntxiv. Qhov no tuaj yeem cuam tshuam cov metabolism los ntawm kev ua kom hnyav nce. Insulin thiab sulfonylureas txo cov ntshav qab zib tab sis ua rau muaj kev tshaib plab thiab rog. Kev txo qis thiab tswj cov piam thaj yuav tsum yooj yim kom zam qhov no. Bioglutide NA-931 peptide kho ob qho teeb meem tsis ua rau koj rog zoo li cov tshuaj ntshav qab zib los ntawm ob txheej txheem.
Cov tshuaj pab tswj glycemic tsis zoo feem ntau. Heavyweights poob phaus zoo tshaj plaws. Kev vam meej ntawm tus kheej txhais tau hais tias cov tshuaj ua haujlwm zoo tshaj plaws rau qhov phem tshaj plaws. Tus neeg mob qhov chaw metabolic tsis ua haujlwm ntawm feem ntau xav tau yuav txhim kho ntau dua nrog cov kev cuam tshuam no. Pib kev kho mob zoo txhim kho kev puas hlwb. Thaum lawv ua tiav, tib neeg pheej mus. Cov neeg mob qhov hnyav thiab ntshav qab zib txo qis tom qab noj zaub mov thiab kev ua neej hloov pauv. Kev hloov kho lawv txoj kev noj qab haus huv. Kev txhawb siab txhawb nqa ntev - lub sijhawm ua tiav. Kev tswj ntshav qab zib yuav ua tau zoo siab lossis nkees.

Txhim kho Metabolic Health Applications ntawm Bioglutide NA-931 Peptide hauv Prediabetes thiab Metabolic Syndrome

Tom ntej: Bioglutide NA-931 peptidetuaj yeem pab tshaj li ntshav qab zib hom 2. Nws kuj tseem yuav pab tau cov teeb meem plab hnyuv me. Prediabetes yog qhia los ntawm kev yoo mov qabzib 100–125 mg / dL lossis HbA1c 5.7%–6.4%. Ntau lab muaj nws, thiab 5-10% yuav mob ntshav qab zib txhua xyoo yog tias tsis muaj dab tsi ua tiav. Kev txav ceev ceev thaum koj nyob ze rau ntshav qab zib tuaj yeem tiv thaiv nws. Kev hloov hauv kev ua neej yog txoj hauv kev zoo tshaj plaws los tswj cov kab mob prediabetes, tab sis lawv nyuaj. Cov tshuaj uas txo qhov hnyav thiab txhawb kev nkag siab ntawm insulin tuaj yeem ua rau qeeb qeeb. Qhov no tuaj yeem tiv thaiv ntshav qab zib hauv ntau ntawm - cov neeg muaj kev pheej hmoo
Lwm qhov kev siv yog metabolic syndrome tsis muaj ntshav qab zib. Cov neeg mob ntshav qab zib muaj tsawg dua kev pheej hmoo ntawm cov hlab plawv dua li cov uas tsis yog- mob ntshav qab zib. Activating ntau receptors txo cov roj cholesterol, ntshav siab, thiab mob. Cov hloov pauv no ncaj qha hloov lawv cov biochemistry, ua rau muaj kab mob plawv. Kev hloov kho rau cov tshuaj metabolic uas tiv thaiv kab mob tab tom pib. Cov tshuaj yav tas los tau tso cai rau kev mob xwb. Ntau tus paub txog cov kab mob prediabetes yog ib qho mob, tsis yog ib qho kev pheej hmoo xwb. Ua ntej nws tshwm sim, peb yuav pib kho pharmacological. Thaum kawg, cov neeg muaj kev pheej hmoo siab tuaj yeem tso tseg ntshav qab zib nrog cov tshuaj muaj txiaj ntsig zoo. Kev noj qab haus huv pej xeem yuav raug kev txom nyem ntau dua.
Txhawb Metabolic Health Thaum Laus
Txawm tias tsis muaj ntshav qab zib, cov metabolism poob qis thaum muaj hnub nyoog. Hnub nyoog- cuam tshuam txog cov nqaij ntshiv, sarcopenia, txo qis insulin- cov ntaub so ntswg rhiab heev thiab ua rau muaj kev pheej hmoo poob Tsis tas li ntawd, tej yam hnyav dua. Txawm nyob rau tib qhov hnyav, visceral rog accumulates. Insulin tsis kam ua phem. Lub sij hawm depletes beta hlwb. Qhov xav tau thiab muaj cov tshuaj insulin sib txawv tsawg dua. Cov neeg laus xav tau IGF-1R-activated leeg tiv thaiv los ntawm bioglutide NA-931 peptide. Kev saib xyuas koj txoj kev noj qab haus huv, kev ywj pheej, thiab lub neej zoo yuav tsum muaj cov leeg muaj zog. Kev tuav cov leeg nqaij thaum poob phaus tuaj yeem thim rov qab kev laus.
Kev txhim kho metabolic hauv cov neeg laus kom muaj kev nyab xeeb yuav tsum tau ceev faj. Kev poob phaus sai yuav ua rau muaj kab mob lossis kev tshaib plab. Peb hu qhov no catabolic stress. Bioglutide NA-931 peptide muaj kev nyab xeeb dua li cov txheej txheem tsis muaj ntaub so ntswg vim nws tiv thaiv cov leeg nqaij. Kev hloov pauv hauv cov metabolism tuaj yeem txhim kho cov neeg laus lub cev thiab lub hlwb. Insulin tsis kam cuam tshuam lub hlwb lub zog thiab Alzheimer's. Tsiaj cov kev tshawb fawb qhia GLP-1R ua kom cov tshuaj tiv thaiv antioxidant. Kev tswj cov piam thaj ntau dua yuav tsis yog qhov txiaj ntsig ntawm kev txawj ntse. Ntau tus receptor agonists tuaj yeem ua rau qeeb kev paub thiab metabolic poob. Qhov no tsuas yog kwv yees, tab sis cov neeg laus pom lawv txaus siab.

Kev Tshawb Fawb Cov Ntawv Thov thiab Kev Txhim Kho Tshuaj
Tsis yog -kev siv tshuaj kho mob rau bioglutide NA-931 peptide. Siv rau kev tshawb fawb metabolism thiab kev tsim tshuaj. Nws tuaj yeem piav qhia yuav ua li cas cov txheej txheem metabolic cuam tshuam tag nrho vim nws ua haujlwm ntau. Paub txog qhov kev sib txuas receptor ua haujlwm zoo tshaj plaws rau kev txhim kho tshuaj yav tom ntej yog pab tau. Cov tuam txhab tshuaj tshawb fawb cov tshuaj tshiab metabolic xav tau siab -purity reference molecules rau kev sib tw txawj ntse thiab mechanism- ntawm- kev tshawb fawb txog kev ua. Qhov no yog siv tau 98%+ ntshiab, kho mob-qib Bioglutide NA-931 peptide. Ib qho yooj yim nkag mus rau kev kawm zoo ntau tus receptor agonists tuaj yeem pab cov kws tshawb fawb txog kev tswj hwm cov metabolism.
Cov molecule ua haujlwm zoo npaum li cas ntawm qhov ncauj qhia tau hais tias lub plab zom mov ua rau peptides ciaj sia. Feem ntau peptide- cov tshuaj hormones raws li tsis muaj txiaj ntsig vim lub plab enzymes zom lawv. Kev nkag siab yuav ua li cas Bioglutide NA-931 peptide kov yeej cov teeb meem no tuaj yeem pab tsim cov tshuaj peptide hauv qhov ncauj. Cov kev kho mob sib txawv tuaj yeem hloov pauv. Tsim cov tshuaj sib xyaw ua ke yog kev tshawb fawb tshiab. Ntau- cov kab mob tiv thaiv kab mob txhawb nqa ntau yam haujlwm lom neeg ib txhij. Cov txheej txheem sib txawv tuaj yeem cuam tshuam. Anti-SGLT2 inhibitors pab lub cev tshem tawm cov piam thaj yam tsis muaj insulin. Cov kev tshawb fawb zoo li no xav tau siab -cov tshuaj sim zoo los ntawm cov tshuaj tsim kho-zoo thiab cov neeg muag khoom raws sijhawm.
Xaus
Zoo heev li osTom ntej: Bioglutide NA-931 peptidetuaj yeem pab cov neeg mob ntshav qab zib hom 2 thiab kev poob phaus nrog lawv cov teeb meem tib lub sijhawm. Nws plaub receptors ua haujlwm ua ke hauv txoj hauv kev uas tsim nyog kom cov leeg noj qab haus huv, tua kev tshaib kev nqhis, zom cov rog, thiab ua kom qabzib. Muaj kev txhim kho loj hauv ob qho tib si tswj cov ntshav qab zib thiab lub cev hnyav, thiab ua kom cov leeg nqaij ntshiv kuj tau pom tias muaj txiaj ntsig.
Muaj teeb meem nrog kev txhaj tshuaj uas ua rau nws nyuaj rau lo nrog lwm yam kev kho mob. Txoj kev ntawm qhov ncauj tau tshem ntawm cov teeb meem no. Qib purity ntau dua 98%, uas yog cov kws tshuaj, ua kom muaj kev ua tau zoo rau kev kawm thiab kev siv tswv yim. Cov tshuaj no tsuas yog txo cov ntshav qab zib los yog pab tib neeg poob phaus; nws kuj hloov ntau qhov chaw ntawm metabolic syndrome. Nws yog tag nrho txoj hauv kev los txhim kho kev noj qab haus huv hauv koj lub plawv thiab cov metabolism.
Cov kab mob metabolic tau kis thoob plaws ntiaj teb, yog li peb xav tau ntau thiab ntau txoj hauv kev tshiab los kho lawv. Cov kws tshawb fawb tau pom tias nws yooj yim dua los hloov pauv thaum peb paub tias cov kev tswj hwm cov metabolism ua haujlwm li cas. Ib qho piv txwv yog Bioglutide NA-931 peptide. Cov tshuaj no tuaj yeem pab txhim kho kev noj qab haus huv metabolic, thiab nws tuaj yeem siv rau hauv chaw kho mob, ua tshuaj tshiab, lossis kawm txog cov metabolism.
FAQ
1. Dab tsi ua rau Bioglutide NA-931 peptide txawv ntawm cov tshuaj noj ntshav qab zib ib leeg?
Bioglutide NA-931 peptide tsom rau plaub qhov chaw metabolic ib txhij. Feem ntau cov tshuaj kho mob ntshav qab zib hom phiaj yog ib qho. Cov no suav nrog IGF-1R, GIPR, GCGR, thiab GLP-1R. Qhov kev ua no ua haujlwm nrog ntau lub tshuab los tswj kev tshaib plab, piam thaj metabolism, rog rog, thiab tiv thaiv cov leeg. Tsis tsuas yog qabzib poob, tab sis metabolism nce. Kev tshawb fawb soj ntsuam pom tau hais tias cov tshuaj no pab cov neeg mob hnyav dua thiab khaws cov leeg nqaij ntau dua li ib leeg-receptor agonists. Lawv tswj cov ntshav qab zib zoo dua li cov tshuaj no.
2. Bioglutide NA-931 peptide puas tuaj yeem pab tiv thaiv ntshav qab zib hauv cov neeg mob ntshav qab zib?
Kev tshawb fawb txhawb lub tswv yim tias Bioglutide NA-931 peptide pab tiv thaiv cov ntshav qab zib hauv cov tib neeg uas muaj kev pheej hmoo siab. Cov tshuaj ua kom poob phaus yooj yim dua thiab insulin ua haujlwm zoo dua. Cov no yog ob txoj hauv kev hloov pauv txoj kev ua neej tuaj yeem tiv thaiv kev mob ntshav qab zib. Cov txiaj ntsig loj hauv metabolic tau tshaj tawm hauv pab pawg neeg mob ntshav qab zib tau hais tias pib kho ua ntej ntshav qab zib yuav txo qis lossis nres nws. Lub hom phiaj tiv thaiv kev sim ua tam sim no txuas ntxiv. Cov kev sim tshuaj uas qhia txog qhov txo qis ntshav qab zib yuav xav tau rau tsoomfwv kom pom zoo rau kev siv tshuaj tiv thaiv.
3. Cov qauv ntawm qhov ncauj ua li cas thiaj li muaj txiaj ntsig zoo piv rau lwm txoj kev txhaj tshuaj?
Bioglutide NA-931 peptide's molecular qauv raug xaiv los txuas rau receptors tom qab kev zom zaub mov. Kev npaj tshuaj kho cov txheej txheem txhim kho plab epithelial absorption, nce bioavailability mus rau qib kho. Qhov ncauj multi-receptor agonists txo cov ntshav qab zib thiab pab cov tib neeg poob phaus nrog rau cov tshuaj txhaj, raws li kev tshawb fawb soj ntsuam. Cov txheej txheem ntawm qhov ncauj tau txais kev txhawb nqa. Qhov solubility no txhim kho cov tshuaj thiab pab cov neeg mob ua raws li lawv cov kev kho mob.
Koom tes nrog BLOOM TECH rau Premium Bioglutide NA-931 Peptide Supply
Nws muaj kev nyab xeeb los yuavTom ntej: Bioglutide NA-931 peptidelos ntawm BLOOM TECH vim tias lawv tsuas yog muag cov tshuaj - qib sib txuas uas ua tau raws li cov kev xav tau nruj ntawm kev tshawb fawb tshuaj thiab kev tshawb fawb soj ntsuam. Peb muaj GMP- ntawv pov thawj, US FDA- ntawv pov thawj, EU- ntawv pov thawj, thiab CFDA- ntawv pov thawj cov chaw tsim khoom uas npog 100,000 square meters. Qhov no ua kom qhov zoo ib yam thiab ua tau raws li cov cai hauv lwm lub tebchaws. Peb tau ua cov organic synthesis thiab kev tswj kom zoo nrog triple-tier tsom xam rau 12 xyoo, yog li peb tuaj yeem muab qib purity siab dua 98% thiab muab tag nrho cov ntaub ntawv koj xav tau rau kev pom zoo kev lis kev cai.
Peb tuaj yeem pab nrog cov haujlwm los ntawm lub chaw kuaj sim mus rau kev tsim khoom loj, txawm tias koj xav tau me me rau cov txheej txheem - ntawm - kev tshawb fawb txog kev nqis tes ua lossis ntau ntau rau cov khoom siv kho mob. Peb cov txuj ci tsim khoom yog hloov tau, thiab peb tus nqi yooj yim to taub . 24 ntawm cov tuam txhab tshuaj loj tshaj plaws thiab cov chaw tshawb fawb hauv ntiaj teb ua haujlwm nrog peb vim peb yog lawv mus- mus rau qhov chaw rau cov tshuaj metabolic tshwj xeeb. Peb xav tsim kom muaj kev sib raug zoo nrog koj ntev -, yog li peb muab cov nqi qis, lub sijhawm tos kom meej, thiab kev pabcuam tshaj lij thoob plaws tag nrho cov txheej txheem kev loj hlob.
Tshawb xyuas BLOOM TECH ntau cov kev pabcuam kom pom tias lawv tuaj yeem pab koj kawm thiab ua kom cov khoom noj qab haus huv sai dua. Hu rau peb pab neeg txhawb nqa tech tam sim ntawd ntawmSales@bloomtechz.comlos tham txog koj cov kev xav tau tshwj xeeb rau Bioglutide NA-931 peptide thiab tshawb xyuas peb cov ntawv teev npe dav dav ntawm ntau dua 250,000 cov tshuaj lom neeg.
Cov ntaub ntawv
1. Müller TD, Finan B, Bloom SR, et al. Glucagon-zoo li peptide 1 (GLP-1) receptor agonists rau kev kho mob rog: molecular mechanisms thiab cov txiaj ntsig kho mob. Nature Reviews Endocrinology. 2019;15(11):643–661.
2. Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide piv rau Semaglutide Ib zaug ib lim piam hauv cov neeg mob uas muaj ntshav qab zib hom 2. Lancet. 2021;398(10295):143–155.
3. Nauck MA, Quast DR, Wefers J, Meier JJ. GLP-1 receptor agonists hauv kev kho mob ntshav qab zib hom 2 - xeev - ntawm - the-art. Molecular Metabolism. 2021; 46:101102.
4. Holst JJ, Rosenkilde MM. GIP raws li Kev Kho Mob Lub Hom Phiaj hauv Kev Mob Ntshav Qab Zib thiab Kev rog: Kev Pom Zoo Los Ntawm Incretin Co-Agonists. Nature Reviews Endocrinology. 2020;16(11):660–672.
5. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Ib zaug ib lub lim tiam rau kev kho mob rog. The New England Journal of Medicine. 2022;387(3):205–216.
6. American Diabetes Association Professional Practice Committee. Cov Qauv Kev Kho Mob hauv Ntshav Qab Zib-2026. Kev Kho Mob Ntshav Qab Zib. 2026;49(Supplement_1).






